Daughaday WH , Emanuele MA, Brooks MH et al. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med1988;319:1434-40.
3.
de Groot JW, Rikhof B., van Doorn J. et al. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer2007;14:979-93.
4.
Daughaday WH , Trivedi B., Baxter RCSerum ‘big insulin-like growth factor II’ from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci U S A1993;90:5823-7.
5.
Bond JJ, Meka S., Baxter RCBinding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J Endocrinol2000;165:253-60.
6.
Jacobson AM, Musen G., Ryan CM et al. Long-term effect of diabetes and its treatment on cognitive function . N Engl J Med2007;356:1842-52.
7.
McNay ECThe impact of recurrent hypoglycemia on cognitive function in aging. Neurobiol Aging2005;26(suppl 1):76-9.
8.
Fujioka M., Okuchi K., Hiramatsu KI et al. Specific changes in human brain after hypoglycemic injury. Stroke1997;28:584-7.
